Publication of inside information pursuant to Article 17 MAR
ENCAVIS AG resolves on capital increase for growth financing and gains Versicherungskammer Bayern as new major shareholder
Hamburg, December 11, 2019 - The Management Board of Encavis AG (ISIN: DE0006095003, Prime Standard), which is listed on the SDAX, today resolved to increase the company"s share capital by up to 4.21% in return for cash contributions on the basis of the authorization granted by the Annual General Meeting on May 18, 2017 and with the approval of the Supervisory Board. The Company"s share capital shall be increased from currently EUR 131,498,147.00 to EUR 137,039,147.00 through the issue of 5,541,000 new bearer shares with a pro rata amount of share capital of EUR 1.00 per share, partially utilizing the existing Authorized Capital 2017. The new shares were subscribed at a price of EUR 8.72 per new share, 3% below the Volume-Weighted-Average-Price of the past five days. The company will receive gross proceeds of around EUR 48 million. Shareholders" subscription rights were excluded.
All new shares are acquired by BayernInvest Kapitalverwaltungsgesellschaft mbH, Munich, acting as a capital management company for and on behalf of BayernInvest BWA-Fonds, a special fund of Versicherungskammer Bayern Versicherungsanstalt des öffentlichen Rechts. ENCAVIS intends to use the proceeds from the capital increase to continue its growth course through further acquisitions of projects.
The new shares will be entitled to dividends from January 1, 2019. Immediately after the registration of the capital increase in the commercial register, the new shares shall be admitted to trading on the regulated market of the Frankfurt Stock Exchange with admission to the sub-segment of the regulated market with additional obligations to the listing (Prime Standard) at the Frankfurt Stock Exchange and on the regulated market of the Hamburg Stock Exchange.
The information contained in this document is not intended for distribution in the USA, Australia, Canada or Japan or for publication in the USA, Australia, Canada or Japan. This document does not constitute an offer to sell or the solicitation of an offer to buy any securities. This document does not constitute an offer of securities for sale in the United States of America. Securities may not be offered or sold in the United States of America absent registration under the U.S. Securities Act of 1933, as amended, or an exemption from registration. The shares of ENCAVIS AG have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and will not be offered or sold in the United States of America.